JPS5587718A - Medicine composition - Google Patents
Medicine compositionInfo
- Publication number
- JPS5587718A JPS5587718A JP16674379A JP16674379A JPS5587718A JP S5587718 A JPS5587718 A JP S5587718A JP 16674379 A JP16674379 A JP 16674379A JP 16674379 A JP16674379 A JP 16674379A JP S5587718 A JPS5587718 A JP S5587718A
- Authority
- JP
- Japan
- Prior art keywords
- medicine composition
- medicine
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1301978 | 1978-12-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5587718A true JPS5587718A (en) | 1980-07-02 |
JPS643846B2 JPS643846B2 (en) | 1989-01-23 |
Family
ID=4388565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16674379A Granted JPS5587718A (en) | 1978-12-21 | 1979-12-20 | Medicine composition |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS5587718A (en) |
KR (1) | KR830001642B1 (en) |
AR (1) | AR240012A1 (en) |
BE (1) | BE880713A (en) |
ZA (1) | ZA796969B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6130534A (en) * | 1984-07-23 | 1986-02-12 | Tooa Eiyoo Kk | Hydrogenated ergot-alkaloid preparation and its preparation |
JPH08510219A (en) * | 1993-05-18 | 1996-10-29 | ビーエーエスエフ アクチエンゲゼルシャフト | Dispensing in the form of solid solution |
JP2003515549A (en) * | 1999-12-03 | 2003-05-07 | ポリケム・ソシエテ・アノニム | Method for producing sustained-release pharmaceutical composition of ergot alkaloid with improved bioavailability and composition thereof |
-
1979
- 1979-12-19 BE BE1/9654A patent/BE880713A/en not_active IP Right Cessation
- 1979-12-20 KR KR1019790004554A patent/KR830001642B1/en active
- 1979-12-20 JP JP16674379A patent/JPS5587718A/en active Granted
- 1979-12-21 ZA ZA00796969A patent/ZA796969B/en unknown
-
1988
- 1988-03-18 AR AR310352A patent/AR240012A1/en active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6130534A (en) * | 1984-07-23 | 1986-02-12 | Tooa Eiyoo Kk | Hydrogenated ergot-alkaloid preparation and its preparation |
JPH08510219A (en) * | 1993-05-18 | 1996-10-29 | ビーエーエスエフ アクチエンゲゼルシャフト | Dispensing in the form of solid solution |
JP2003515549A (en) * | 1999-12-03 | 2003-05-07 | ポリケム・ソシエテ・アノニム | Method for producing sustained-release pharmaceutical composition of ergot alkaloid with improved bioavailability and composition thereof |
JP4965784B2 (en) * | 1999-12-03 | 2012-07-04 | ポリケム・ソシエテ・アノニム | Process for producing sustained release pharmaceutical composition of ergot alkaloid with improved bioavailability and composition thereof |
Also Published As
Publication number | Publication date |
---|---|
KR830000899A (en) | 1983-04-28 |
ZA796969B (en) | 1981-07-29 |
BE880713A (en) | 1980-06-19 |
JPS643846B2 (en) | 1989-01-23 |
KR830001642B1 (en) | 1983-08-22 |
AR240012A1 (en) | 1990-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2039738B (en) | Inflammation - preventing pharmaceutical composition | |
JPS54132223A (en) | Novel pharmaceutical composition | |
JPS54155292A (en) | Photoopolymerizable composition | |
JPS5571734A (en) | Composition | |
JPS5523187A (en) | Photoohardening composition | |
JPS54158452A (en) | Composition | |
JPS5580451A (en) | Composition | |
JPS54139654A (en) | Composition | |
JPS5523186A (en) | Photoohardening composition | |
JPS54107993A (en) | Alphaacyanoacrylate composition | |
JPS54147931A (en) | Antiiulcer composition | |
GB2034587B (en) | Pharmaceutical compositions | |
JPS54154516A (en) | Pharmaceutical composition | |
GB2031727B (en) | Pharmaceutical compositions | |
GB2039218B (en) | Pharmaceutical compositions | |
GR64830B (en) | Disinfectaut composition | |
JPS5527168A (en) | Drug composition | |
JPS54147934A (en) | Antiiangina composition | |
JPS5540677A (en) | Medical composition | |
JPS5587718A (en) | Medicine composition | |
JPS56127311A (en) | Novel medicine composition | |
ZA794484B (en) | Pharmaceutical compositions | |
GB2026532B (en) | Dtergent composition | |
ZA791032B (en) | Pharmaceutical compositions | |
JPS5560538A (en) | Composition |